Global Cancer Vaccines Market Research Report 2017 - Research and Markets
Thursday, 05 October 2017 04:06
Oct. 5, 2017 14:02 UTC

Global Cancer Vaccines Market Research Report 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)-- The "Global Cancer Vaccines Market - Segmented by Type, Technology, End User and Geography 2017 - 2022" report has been added to Research and Markets' offering.

The global cancer vaccines market to grow at a CAGR of 12-18% over the period (2017 - 2022). It is currently estimated to be valued at USD 2.1 billion for the year 2015.

The market for cancer vaccines is much smaller than other cancer therapeutic categories. The size of the market can be attributed to the nascent stages of industry life cycle and the late introduction of the vaccines in the market. To tap this market, many global companies are actively investing in cancer vaccine development. The market penetration is expected to increase with the increase in competition among the various pharmaceutical companies to obtain a larger portion of this market.

North America dominates the market, with the U.S. accounting for a major market share. However, Asia is poised to grow at the highest CAGR during the forecast period owing to the governmental initiatives, rising focus of major players on the Indian vaccine technology market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI in these regions.

The Global Cancer Vaccines Market is segmented based on:

  • Technology
  • Subunit Vaccines
  • Live Attenuated Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Recombinant Vector Vaccines
  • Toxoid Vaccines
  • Synthetic Vaccines
  • Dendritic Cell Vaccines


  • Preventive Vaccines
  • Therapeutic Vaccines
  • Disease Indication
  • Cervical cancer
  • Others


  • Increasing cancer cases
  • Technological developments
  • Drug innovations with regard to the cancer
  • Government initiatives
  • Rise in aging populace
  • Advanced health care services
  • Upsurge in awareness about cancer and their available therapies in the market
  • Increasing health care expenditure


  • Cold chain, or temperature-controlled supply chain, management
  • Low accessibility to vaccines in remote areas
  • Stringent regulatory procedures

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Introduction

4. Market Overview

5. Porters Five Force Analysis

6. Market Segmentation

7. Competitive Landscape

8. Company Profiles

  • AstraZeneca plc
  • Aduro BioTech
  • Cytos
  • Galena Biopharma
  • Juvaris Biotherapeutics
  • MedImmune
  • Oxford BioMedica
  • Prima BioMed
  • GlaxoSmithKline
  • Sanofi
  • Merk&co
  • Ubivac
  • Vaccinogen

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cancer Vaccines

Source: Research and Markets

BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and

Error. Page cannot be displayed. Please contact your service provider for more details. (5)

investor relation services from various entities and
firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!